多模态MRI标志物变化可预测脑小血管病痴呆风险
该前瞻性研究纳入99例脑小血管病患者,每年进行多模态MRI和认知评估,随访5年。结果显示18例(18.2%)进展为痴呆,DTI白质微结构损伤进展和新发腔隙灶与认知下降相关,MRI变量变化模型预测痴呆的C统计量为0.85。
要点
- DTI白质微结构损伤进展和新发腔隙灶预测认知下降。
- 白质高信号增长和DTI恶化预测痴呆进展。
- MRI变化可在认知变化可检测前预测痴呆。
核心结论
- 多模态MRI标志物(包括DTI)的变化可预测脑小血管病患者的认知下降和痴呆进展。
研究设计与样本
- 前瞻性队列研究(St George's Cognition and Neuroimaging in Stroke研究),纳入99例脑小血管病患者,每年多模态MRI共3年,认知评估每年共5年。
主要发现
- 5年随访中18例(18.2%)进展为痴呆。
- 新发腔隙灶和DTI白质微结构损伤增加速率与执行功能和全局功能下降相关。
- 白质高信号增长和DTI白质微结构恶化预测痴呆进展。
- 包含MRI变量变化及基线值的模型正确分类痴呆进展的C统计量为0.85。
临床怎么用
- MRI标志物(包括DTI)可作为监测脑小血管病疾病进展和评估治疗干预的替代生物标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine whether MRI markers, including diffusion tensor imaging (DTI), can predict cognitive decline and dementia in patients with cerebral small vessel disease (SVD). METHODS: In the prospective St George's Cognition and Neuroimaging in Stroke study, multimodal MRI was performed annually for 3 years and cognitive assessments annually for 5 years in a cohort of 99 patients with SVD, defined as symptomatic lacunar stroke and confluent white matter hyperintensities (WMH). Progression to dementia was determined in all patients. Progression of WMH, brain volume, lacunes, cerebral microbleeds, and a DTI measure (the normalized peak height of the mean diffusivity histogram distribution) as a marker of white matter microstructural damage were determined. RESULTS: Over 5 years of follow-up, 18 patients (18.2%) progressed to dementia. A significant change in all MRI markers, representing deterioration, was observed. The presence of new lacunes, and rate of increase in white matter microstructural damage on DTI, correlated with both decline in executive function and global functioning. Growth of WMH and deterioration of white matter microstructure on DTI predicted progression to dementia. A model including change in MRI variables together with their baseline values correctly classified progression to dementia with a C statistic of 0.85. CONCLUSIONS: This longitudinal prospective study provides evidence that change in MRI measures including DTI, over time durations during which cognitive change is not detectable, predicts cognitive decline and progression to dementia. It supports the use of MRI measures, including DTI, as useful surrogate biomarkers to monitor disease and assess therapeutic interventions.
引用
- Zeestraten EA, Lawrence AJ, Lambert C, et al. Change in multimodal MRI markers predicts dementia risk in cerebral small vessel disease. Neurology. 2017. PMID: 28978655. doi:10.1212/WNL.0000000000004594
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。